Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Angocin Mannose Plus-Repha
- Development stage
- Unknown
- Lead developer
- Repha
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Angocin Mannose Plus-Repha is a multi-component dietary supplement developed by Repha GmbH, designed to support bladder health and the immune system. It features a 5-component combination consisting of D-mannose, Qcran cranberry powder, watercress extract (*Nasturtium officinale*), Vitamin B3 (niacin), and Vitamin D3. D-mannose and cranberry proanthocyanidins work by inhibiting the adhesion of pathogenic bacteria, such as *E. coli*, to the urinary tract epithelium. Watercress provides glucosinolates (mustard oils), which have traditional use in urinary health. Niacin contributes to the maintenance of healthy mucous membranes, while Vitamin D3 supports normal immune function. The product is administered as a direct-stick powder that dissolves in the mouth without the need for water.
- Brand names
- Angocin Mannose Plus-RephaAngocin Mannose Plus
02
Targets
FimH (Type 1 fimbrial adhesin)
Beyond the preview
Go deeper on Angocin Mannose Plus-Repha.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Angocin Mannose Plus-Repha.